Bitcoin’s success reflects a growing shift in how the world approaches not only cryptocurrency but also financial markets as ...

The fast-food chain argues in a counterclaim against Paradigm Investment Group that the operator is the only traditional ...

RBI's big beautiful monetary policy, rising market activity a cause for concern, global growth slows but markets are soaring, ...

When a retailer offers a chatbot to communicate with customers and solve their queries, or when a bank sends an SMS for ...

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.

How Rick Carter, producer designer of blockbusters for Steven Spielberg and Jim Cameron, sees GenAI emerging as a ...

The prior article in the two-part series challenged the traditional view of economics as merely the management of scarce ...

Vineeth Gogineni is a Manager at Bain & Company, based in the Dallas office, serving private and public sector clients across ...

With common adversaries, the climate and nuclear disarmament movements have an unexplored potential to work together.

Axsome Therapeutics received a refusal-to-file letter from the Food and Drug Administration for its new drug application for its fibromyalgia drug AXS-14.

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...